PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 205 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $11,188,000 | -48.3% | 244,008 | -33.3% | 0.41% | -49.6% |
| Q2 2018 | $21,636,000 | -14.5% | 365,787 | -1.6% | 0.82% | -19.5% |
| Q1 2018 | $25,304,000 | -36.4% | 371,840 | -7.7% | 1.01% | -33.9% |
| Q4 2017 | $39,804,000 | -10.2% | 402,668 | +8.8% | 1.53% | -15.0% |
| Q3 2017 | $44,312,000 | +59.6% | 370,035 | +16.5% | 1.80% | +55.4% |
| Q2 2017 | $27,765,000 | +96.8% | 317,680 | -16.2% | 1.16% | +100.3% |
| Q1 2017 | $14,110,000 | +124.1% | 379,289 | +1102.0% | 0.58% | +83.2% |
| Q1 2015 | $6,297,000 | -34.4% | 31,556 | -37.8% | 0.32% | -37.9% |
| Q4 2014 | $9,600,000 | +36.0% | 50,721 | +71.5% | 0.51% | +21.5% |
| Q3 2014 | $7,057,000 | – | 29,580 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |